Yablonka Uri - Insider Non-Derivative Transactions at BRAINSTORM CELL THERAPEUTICS INC. (BCLI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 11, 2024, Yablonka Uri's relationship to BRAINSTORM CELL THERAPEUTICS INC. (BCLI) is Director,Officer (EVP & Chief Business Officer), and currently has 126,969 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BCLI insiders.
Data Source: SEC.
Yablonka Uri - Insider Non-Derivative Transactions at BCLI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 12, 2024 | Acquisition -- (Common Stock) | 109426 | 0 | 126969 |